Healthcare organizations urged HHS Secretary Robert F. Kennedy Jr. to protect the U.S. Preventive Services Task Force, warning that disruptions could threaten access to preventive care for millions of Americans. The post 60 Cancer Patient and Provider Orgs Call on RFK Jr. to Protect USPSTF appeared first on MedCity News.
Higher market concentration in Medicare Advantage insurance markets may lower the incentive for insurers to compete for potential enrollees by making plans more appealing through more comprehensive benefits or lower costs.
A prime example of elderspeak: Cindy Smith was visiting her father in his assisted living apartment in Roseville, California. An aide who was trying to induce him to do something — Smith no longer remembers exactly what — said, “Let me help you, sweetheart.” “He just gave her The Look — under his bushy eyebrows…
These tools are worth implementing. They are not worth implementing without the right preparation. The post What Healthcare Leaders Should Know Before Implementing AI-Powered Documentation Tools appeared first on MedCity News.
Booster Therapeutics’ small molecules activate the 20S proteasome, a component of cells that gets rid of misfolded proteins. Parkinson’s and Alzheimer’s are potential disease targets for the startup, which launched with $15 million in seed financing. The post Startup Booster Therapeutics Launches to Usher In Next Wave of Protein-Degrading Drugs appeared first on MedCity News.
Chris Darland is CEO of Peerbridge Health, which is the maker of a “3 lead to 12 lead” EKG patch that can give a better view of overall cardiac health than what’s on the market now–which tend to specialize in AFIB. Chris thinks that the Peerbridge Cor product will lead to a new world where…
Oren Nissim is the CEO of Brook-ai which is been making some waves in the remote care space. Their goals is to use remote patient monitoring to help providers reduce readmissions, and help patients stay on their care plans. For example they get more then 50% of their populations into hypertension control within 10 weeks,…
AstraZeneca’s EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases. EsoBiotec’s allogeneic cell therapies are made by the in vivo reprogramming of a patient’s immune cells. The post AstraZeneca Aims to Make Cell…
In National Academy of Medicine program, three health professionals will spend a year in state legislative and executive branch offices in Colorado, Pennsylvania, and Wisconsin
Nearly a year after the Biden administration gave Florida the green light to become the first state to import lower-cost prescription drugs from Canada — a longtime goal of politicians across the political spectrum, including President-elect Donald Trump — the program has yet to begin. Florida Gov. Ron DeSantis hailed the FDA’s approval of his…